Part,  Chapter, Paragraph

 1   II,     5.  5.  3|        alliances and networks of excellence on a European level in order
 2   II,     5.  5.  3|  National Institute for Clinical Excellence~PMR~Proportionate Mortality
 3   II,     5.  5.  3|  National Institute for Clinical Excellence Guideline on MS Services (
 4   II,     5.  5.  3|  National Institute for Clinical Excellence Guideline on the management
 5   II,     5. 11.  7|          for health and clinical excellence (NICE) (2007): clinical
 6   II,     7.  6    |         The number of centres of excellence for injury prevention in
 7   II,     9.  1.  2|       services within centres of excellence treating a sufficient volume
 8   II,     9.  2.  3|   National Institute of Clinical Excellence (NICE) guidance on prescribing
 9   II,     9.  2.  8|   National Institute of Clinical Excellence~RPGs~Regional Priority Goals~ ~
10  III,    10.  4.  2|         independence, scientific excellence and transparency. It was
11   IV,    11.Acr    | Institute of Health and Clinical Excellence~OEOs~Organ Exchange Organizations~
12   IV,    11.  1.  5| Institute of Health and Clinical Excellence (NICE), are increasingly
13   IV,    11.  2.  2| Institute of Health and Clinical Excellence. The methodology used for
14   IV,    11.  4    |          for Health and Clinical Excellence (NICE) (Walley, 2007) .~ ~
15   IV,    12.  4    |             To foster scientific excellence in the evaluation and supervision
16   IV,    13.Acr    | Institute of Health and Clinical Excellence. The methodology used for